Stockreport

Assembly Biosciences Presents Data Highlighting Next-Generation HBV Core Protein Inhibitors at EASL 2019

Assembly Biosciences, Inc.  (ASMB) 
Last assembly biosciences, inc. earnings: 3/4 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.assemblybio.com/investor-relations
PDF Phase 1a study of ABI-H2158 demonstrated safety, tolerability and achievement of target liver concentrations ABI-H3733 demonstrated enhanced potency in preclinical stud [Read more]